United Microelectronics Corp (UMC) Stock Price Today
Aura AI Summary
Key Stats
- $53.90BMarket Cap
- -Volume
- TechnologySector
- $28.0252W High
- $6.5852W Low
- -Typical Hold Time
- $51.50BEnterprise Value
- 1.94%Div Yield
- -Trading Activity
Track United Microelectronics Corp (UMC) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, United Microelectronics Corp has traded between a low of $6.58 and a high of $28.02, highlighting its annual price range. Buy and sell United Microelectronics Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Most Recent News
Embedded LLM launches TokenVisor Spaces for governed AI agent services on AMD-powered clouds.
Embedded LLM has introduced TokenVisor Spaces, a new product that enables AI cloud operators and enterprises to run governed, auditable AI agent services on AMD-powered infrastructure. The solution combines AMD EPYC CPUs for agent execution and AMD I...

Bloom Energy set for major growth with AI demand and Oracle contract boosting Q2 earnings forecast.
Bloom Energy is poised for significant growth driven by rising AI demand and a major contract with Oracle, which may purchase up to 2.8 gigawatts of its fuel cells. RBC Capital maintains an "Outperform" rating, reflecting confidence in the company's ...

Over 80 companies develop 90+ molecular glues, advancing treatments for cancer and other diseases.
DelveInsight reports a competitive landscape with 80+ companies developing over 90 molecular glue therapies targeting diseases like cancer, immunology, and neurodegeneration. These small molecules promote protein degradation to treat previously 'undr...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.